share_log

INVESTOR DEADLINE NEXT WEEK: Enovix Corporation F/k/a Rodgers Silicon Valley Acquisition Corp. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENVX

INVESTOR DEADLINE NEXT WEEK: Enovix Corporation F/k/a Rodgers Silicon Valley Acquisition Corp. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENVX

下周投资者截止日期:Enovix Corporation f/k/A Rodgers 硅谷收购公司蒙受重大损失的投资者有机会提起集体诉讼——ENVX
newsfile ·  2023/03/02 09:15

San Diego, California--(Newsfile Corp. - March 1, 2023) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enovix Corporation f/k/a Rodgers Silicon Valley Acquisition Corp. (NASDAQ: ENVX) common stock between February 22, 2021 and January 3, 2023, inclusive (the "Class Period") have until Tuesday, March 7, 2023 to seek appointment as lead plaintiff in the Enovix class action lawsuit. Captioned Twitchell v. Enovix Corporation, No. 23-cv-00071 (N.D. Cal.), the Enovix class action lawsuit charges Enovix and as certain of its top executives with violations of the Securities Exchange Act of 1934. A subsequently filed complaint, Rosin v. Enovix Corporation, No. 23-cv-00372 (N.D. Cal.), is also pending in the Northern District of California.

加利福尼亚州圣地亚哥-(Newsfile Corp.-2023年3月1日)-Robbins Geller Rudman&Dowd LLP宣布在2021年2月22日至2023年1月3日(首尾两天包括在内)期间(包括首尾两天)购买Enovix Corporation f/k/a罗杰斯硅谷收购公司(ENVX)普通股的购买人或收购人可以在2023年3月7日(星期二)之前寻求被任命为Enovix集体诉讼。标题Twitchell诉Enovix公司案,编号23-cv-00071(北加州),Enovix集体诉讼起诉Enovix该公司的某些高管违反了1934年的《证券交易法》。随后提出了申诉,Rosin诉Enovix公司案,编号23-cv-00372(北加州),也在加利福尼亚州北区悬而未决。

If you suffered substantial losses and wish to serve as lead plaintiff of the Enovix class action lawsuit, please provide your information here:

如果你遭受了重大损失,并希望担任Enovix集体诉讼,请在此处提供您的信息:

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com.

你也可以联系律师J.C.桑切斯 通过拨打800/449-4900或发送电子邮件至邮箱:jsanchez@rgrdlaw.com.

CASE ALLEGATIONS: Enovix purports to design, develop, and manufacture silicon-anode lithium-ion batteries using proprietary 3D cell architecture, which Enovix claims allows its batteries to achieve higher energy density. On July 14, 2021, Enovix was officially acquired by Rodgers Silicon Valley Acquisition Corp., a special purpose acquisition company (commonly known as a SPAC or blank-check company). Just months before the merger, Enovix received key equipment to establish its first manufacturing line at its "Fab-1" facility in Fremont, California.

案件指控:Enovix声称使用专有的3D电池架构设计、开发和制造硅阳极锂离子电池,Enovix声称这使其电池能够实现更高的能量密度。2021年7月14日,Enovix被罗杰斯硅谷收购公司正式收购,罗杰斯硅谷收购公司是一家特殊目的收购公司(俗称SPAC或空白支票公司)。就在合并前几个月,Enovix收到了关键设备,在其位于加利福尼亚州弗里蒙特的“Fab-1”工厂建立了第一条生产线。

The Enovix class action lawsuit alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose material adverse facts about Enovix's revenue and ability to manufacture its proprietary battery technology. For example, as the Enovix class action lawsuit alleges, Fab-1's supposedly "automated" manufacturing lines were beset by problems that required significant manual intervention to produce batteries. In addition, machines that were meant to yield 550 batteries per hour could only complete around 100.

这个Enovix集体诉讼称,在整个集团期间,被告作出虚假和/或误导性陈述和/或未能披露有关Enovix收入和制造其专有电池技术能力的重大不利事实。例如,作为Enovix集体诉讼称,FAB-1所谓的“自动化”生产线受到问题的困扰,需要大量人工干预才能生产电池。此外,原本打算每小时生产550块电池的机器只能完成大约100块电池。

On November 1, 2022, Enovix announced it realized just $8,000 in revenue for the third quarter of fiscal year 2022. Enovix also revealed that it would be "dialing back" its work on improving existing manufacturing lines to focus on its future manufacturing lines. Additionally, Enovix revealed it anticipated producing fewer than one million batteries in 2023. On this news, Enovix's stock price declined approximately 44%.

2022年11月1日,Enovix宣布2022财年第三季度收入仅为8000美元。Enovix还透露,将“缩减”改善现有生产线的工作,专注于未来的生产线。此外,Enovix透露,预计2023年电池产量不到100万块。消息传出后,Enovix的股价下跌了约44%。

Then, on January 3, 2023, defendant Thurman J. Rogers, Enovix's Executive Chairman, revealed that Enovix's second production facility and future manufacturing lines would be delayed by several additional months because of equipment failures. On this news, Enovix's stock price declined an additional 41%, further damaging investors.

2023年1月3日,被告、Enovix执行主席瑟曼·J·罗杰斯透露,由于设备故障,Enovix的第二个生产设施和未来的生产线将再推迟几个月。消息传出后,Enovix的股价进一步下跌了41%,进一步损害了投资者的利益。

Robbins Geller has launched a dedicated SPAC Task Force to protect investors in blank check companies and seek redress for corporate malfeasance. Comprised of experienced litigators, investigators, and forensic accountants, the SPAC Task Force is dedicated to rooting out and prosecuting fraud on behalf of injured SPAC investors. The rise in blank check financing poses unique risks to investors. Robbins Geller's SPAC Task Force represents the vanguard of ensuring integrity, honesty, and justice in this rapidly developing investment arena.

罗宾斯·盖勒推出了一个专门的SPAC特别工作组保护空白支票公司的投资者,并为公司的渎职行为寻求补偿。SPAC特别工作组由经验丰富的诉讼律师、调查人员和法医会计师组成,致力于根除并代表受伤的SPAC投资者起诉欺诈行为。空白支票融资的兴起给投资者带来了独特的风险。罗宾斯·盖勒的SPAC特别工作组代表着在这个快速发展的投资领域确保诚信、诚实和正义的先锋。

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Enovix common stock during the Class Period to seek appointment as lead plaintiff in the Enovix class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Enovix class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Enovix class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Enovix class action lawsuit.

主要原告程序:1995年《私人证券诉讼改革法》允许任何在类期间购买或收购Enovix普通股的投资者寻求被任命为Enovix集体诉讼。主要原告通常是在被推定的阶级所寻求的救济中具有最大经济利益的动作者,他也是被推定的阶级中的典型和适当的。主要原告代表所有其他班级成员指示Enovix集体诉讼。首席原告可以选择其选择的律师事务所对Enovix集体诉讼。投资者在未来任何潜在复苏中分享的能力并不取决于作为Enovix集体诉讼。

ABOUT ROBBINS GELLER: Robbins Geller is one of the world's leading complex class action firms representing plaintiffs in securities fraud cases. The Firm is ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report for recovering nearly $2 billion for investors in 2021 – more than triple the amount recovered by any other plaintiffs' firm. With 200 lawyers in 9 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

关于罗宾斯·盖勒:Robbins Geller是世界领先的复杂集体诉讼公司之一,在证券欺诈案件中代表原告。在最新的ISS证券集体诉讼服务50强报告中,该公司因在2021年为投资者追回近20亿美元而排名第一--是其他原告公司追回的金额的三倍多。罗宾斯·盖勒在9个办公室拥有200名律师,是世界上最大的原告律师事务所之一,该律师事务所的律师获得了历史上许多最大的证券集体诉讼追回,包括有史以来最大的证券集体诉讼追回-72亿美元-在安然公司,美国证券交易委员会。利蒂格。有关更多信息,请访问以下页面:

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

律师广告。
过去的结果并不能保证未来的结果。
服务可以由我们任何办公室的律师执行。

Contact:
Robbins Geller Rudman & Dowd LLP
655 W. Broadway, Suite 1900, San Diego, CA 92101
J.C. Sanchez, 800-449-4900
jsanchez@rgrdlaw.com

联系方式:
Robbins Geller Rudman&Dowd LLP
655 W.百老汇,1900年套房,加州圣地亚哥,92101
J.C.桑切斯,800-449-4900
邮箱:jsanchez@rgrdlaw.com

To view the source version of this press release, please visit

要查看本新闻稿的源版本,请访问

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发